Literature DB >> 16791628

[The overactive bladder during childhood: when and how should it be treated?].

D Schultz-Lampel1.   

Abstract

Enuresis is one of the most frequent urinary symptoms in children. 80% suffer from primary enuresis nocturna. 20% have urinary incontinence with additional symptoms of frequency, urgency and daytime incontinence, which is also defined in children as overactive bladder in absence of urinary tract infections, neurological, anatomical or further local pathology (OAB in childhood). The underlying pathophysiology is a maturation arrest of the bladder control resulting in detrusor hyperactivity. In most of the cases the differentiation between enuresis and OAB is easily possible with non-invasive primary diagnostic procedures. Invasive diagnostic tools like video urodynamic studies may become necessary when first-line therapy fails. The treatment options comprise bladder training with timed voiding and drink protocols (urotherapy) as well as pharmacologic relaxation of detrusor instability by anticholinergic drugs.

Entities:  

Mesh:

Year:  2006        PMID: 16791628     DOI: 10.1007/s00120-006-1077-8

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  9 in total

1.  Efficacy and safety of oxybutynin in children with detrusor hyperreflexia secondary to neurogenic bladder dysfunction.

Authors:  Israel Franco; Mark Horowitz; Richard Grady; Richard C Adams; Tom P V M de Jong; Kelly Lindert; Detlef Albrecht
Journal:  J Urol       Date:  2005-01       Impact factor: 7.450

2.  The overactive bladder in childhood: long-term results with conservative management.

Authors:  M J Curran; M Kaefer; C Peters; E Logigian; S B Bauer
Journal:  J Urol       Date:  2000-02       Impact factor: 7.450

3.  Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartrate in children with diurnal urinary incontinence.

Authors:  Y Reinberg; J Crocker; J Wolpert; D Vandersteen
Journal:  J Urol       Date:  2003-01       Impact factor: 7.450

Review 4.  Contemporary and emerging drug treatments for urinary incontinence in children.

Authors:  Mitchell R Humphreys; Yuri E Reinberg
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

5.  Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?

Authors:  Selcuk Yucel; Erdem Akkaya; Erol Guntekin; Erdal Kukul; Ahmet Danisman; Sema Akman; Mehmet Baykara
Journal:  Urology       Date:  2005-02       Impact factor: 2.649

6.  An empirical treatment algorithm for incontinent children.

Authors:  Arne-Daniela Marschall-Kehrel; Gerd Mürtz; Guus Kramer; Klaus-Peter Jünemann; Helmut Madersbacher
Journal:  J Urol       Date:  2004-06       Impact factor: 7.450

Review 7.  [Overactive bladder syndrome in children].

Authors:  C Persson de Geeter
Journal:  Urologe A       Date:  2004-07       Impact factor: 0.639

8.  Outcome of overactive bladder in children.

Authors:  Stanley Hellerstein; Amy Ajans Zguta
Journal:  Clin Pediatr (Phila)       Date:  2003 Jul-Aug       Impact factor: 1.168

9.  Trospium chloride for the treatment of detrusor instability in children.

Authors:  P Lopez Pereira; C Miguelez; J Caffarati; F Estornell; A Anguera
Journal:  J Urol       Date:  2003-11       Impact factor: 7.450

  9 in total
  2 in total

1.  Muscarinic receptor expression and receptor-mediated detrusor contraction: comparison of juvenile and adult porcine tissue.

Authors:  Melinda Wuest; Birgit Eichhorn; Manfred Braeter; Gerhard Strugala; Martin C Michel; Ursula Ravens
Journal:  Pflugers Arch       Date:  2007-12-21       Impact factor: 3.657

Review 2.  Urinary incontinence in children.

Authors:  Daniela Schultz-Lampel; Christian Steuber; Peter F Hoyer; Christian J Bachmann; Daniela Marschall-Kehrel; Hannsjörg Bachmann
Journal:  Dtsch Arztebl Int       Date:  2011-09-16       Impact factor: 5.594

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.